COMMUNIQUÉS West-GlobeNewswire

-
Avicanna Announces its 5th Medical Symposium on Cannabinoid-based Medicine
07/04/2025 -
TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals
07/04/2025 -
Kraig Biocraft Laboratories is Happy to Announce its New Director of Molecular Biology as it Accelerates Advanced Fibers Development
07/04/2025 -
Zenas BioPharma Appoints Haley Laken, Ph.D., as Chief Scientific Officer
07/04/2025 -
Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity
07/04/2025 -
ADMA Biologics Statement on Tariffs
07/04/2025 -
Atwater Brewery Releases Atwater Light: Detroit’s Premium Light Craft Beer
07/04/2025 -
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
07/04/2025 -
Castle Biosciences Honored with a Top Workplaces USA Award for Fourth Consecutive Year
07/04/2025 -
Pharvaris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
07/04/2025 -
Telix Appoints Paul Schaffer as Chief Technology Officer
07/04/2025 -
Serina Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference
07/04/2025 -
Transactions under Novonesis’ share buyback program
07/04/2025 -
Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study
07/04/2025 -
European Commission approves Johnson & Johnson’s subcutaneous DARZALEX® (daratumumab)-based quadruplet regimen for the treatment of patients with newly diagnosed multiple myeloma, regardless of transplant eligibility
07/04/2025 -
LIfT BioSciences Appoints Mark A. Exley as Chief Scientific Officer
07/04/2025 -
Angelini Ventures Appoints Seasoned Life Sciences Investor, Dr. Regina Hodits, as Managing Director
07/04/2025 -
Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with Acquired Hypothalamic Obesity
06/04/2025 -
Scarless MTF Breast Augmentation Performed by Seattle Plastic Surgeon
05/04/2025
Pages